* LifeMD Inc LFMD.OQ LFMD.O is expected to show a rise
in
quarterly revenue when it reports results on November 10.
* The New York City-based company is expected to report a
27.6% increase in revenue to $31.845 million from $24.95 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for LifeMD Inc is for a
loss
of 28 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LifeMD Inc
is
$8, above its last closing price of $2.07.
This summary was machine generated November 9 at 02:40 GMT. All
figures in US dollars unless otherwise stated